Expression and Regulation of Soluble Epoxide Hydrolase in Adipose Tissue
Open Access
- 1 March 2010
- Vol. 18 (3), 489-498
- https://doi.org/10.1038/oby.2009.227
Abstract
Obesity is an increasingly important public health issue reaching epidemic proportions. Visceral obesity has been defined as an important element of the metabolic syndrome and expansion of the viscer...Keywords
This publication has 60 references indexed in Scilit:
- Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophyProceedings of the National Academy of Sciences, 2009
- Opposite Regulation of Cholesterol Levels by the Phosphatase and Hydrolase Domains of Soluble Epoxide HydrolaseJournal of Biological Chemistry, 2008
- Soluble Epoxide Hydrolase Inhibitors Reduce the Development of Atherosclerosis in Apolipoprotein E-Knockout Mouse ModelJournal of Cardiovascular Pharmacology, 2008
- Fat and Beyond: The Diverse Biology of PPARγAnnual Review of Biochemistry, 2008
- Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivoProceedings of the National Academy of Sciences, 2007
- Compensatory Mechanism for Homeostatic Blood Pressure Regulation in Ephx2 Gene-disrupted MicePublished by Elsevier BV ,2007
- Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular systemTrends in Pharmacological Sciences, 2007
- An Orally Active Epoxide Hydrolase Inhibitor Lowers Blood Pressure and Provides Renal Protection in Salt-Sensitive HypertensionHypertension, 2005
- Vascular localization of soluble epoxide hydrolase in the human kidneyAmerican Journal of Physiology-Renal Physiology, 2004
- PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancerTrends in Pharmacological Sciences, 2000